Supplement GMPs Should Proceed Despite Economic Concerns - CRN, Rexall
This article was originally published in The Tan Sheet
Executive Summary
Concerns over the economic burden that small companies will face when implementing Good Manufacturing Practices for dietary supplements should not delay or unduly affect FDA's rulemaking, industry commenters advise.